Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate

被引：58

作者：

Goodman, D ^{[1
]}

Pamer, E ^{[1
]}

Jakubowski, A ^{[1
]}

Morris, C ^{[1
]}

Sepkowitz, K ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2002年 / 35卷 / 03期

关键词：

D O I：

10.1086/341305

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We report a case of invasive trichosporonosis due to Trichosporon beigelii originating in the left wrist of a bone marrow transplant recipient who was receiving caspofungin acetate as prophylaxis against invasive Aspergillus infection. While the patient's neutrophil count was recovering, treatment with fluconazole and amphotericin B lipid complex resulted in a complete clinical response.

引用

收藏

页码：E35 / E36

页数：2

相关论文

共 12 条

[1] AZOLE THERAPY FOR TRICHOSPORONOSIS - CLINICAL-EVALUATION OF 8 PATIENTS, EXPERIMENTAL-THERAPY FOR MURINE INFECTION, AND REVIEW [J].

ANAISSIE, E ;

GOKASLAN, A ;

HACHEM, R ;

RUBIN, R ;

GRIFFIN, G ;

ROBINSON, R ;

SOBEL, J ;

BODEY, G .

CLINICAL INFECTIOUS DISEASES, 1992, 15 (05) :781-787

[2] COMPARATIVE EFFICACIES OF AMPHOTERICIN-B, TRIAZOLES, AND COMBINATION OF BOTH AS EXPERIMENTAL-THERAPY FOR MURINE TRICHOSPORONOSIS [J].

ANAISSIE, EJ ;

HACHEM, R ;

KARYOTAKIS, NC ;

GOKASLAN, A ;

DIGNANI, MC ;

STEPHENS, LC ;

TINU, CK .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) :2541-2544

[3] Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts [J].

Espinel-Ingroff, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2950-2956

[4]

GOLD JWM, 1981, CANCER, V48, P2163, DOI 10.1002/1097-0142(19811115)48:10&lt

[5]

2163::AID-CNCR2820481008&gt

[6]

3.0.CO

[7]

2-T

[8]

MARTINO P, 1990, REV INFECT DIS, V12, P570

[9]

*MERCK, 2001, CANC PACK INS

[10] In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi [J].

Tawara, S ;

Ikeda, F ;

Maki, K ;

Morishita, Y ;

Otomo, K ;

Teratani, N ;

Goto, T ;

Tomishima, M ;

Ohki, H ;

Yamada, A ;

Kawabata, K ;

Takasugi, H ;

Sakane, K ;

Tanaka, H ;

Matsumo, F ;

Kuwahara, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :57-62